Two Sigma Advisers
ALXO icon

Two Sigma Advisers’s ALX Oncology ALXO Stock Holding History

Two Sigma Advisers’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-710,400
Closed -$803K – 99
2025
Q4 		$803K Sell
710,400
-9,400
-1% -$14.2K ﹤0.01% 1596
2025
Q3 		$1.32M Buy
719,800
+16,500
+2% +$14.3K ﹤0.01% 1326
2025
Q2 		$292K Buy
703,300
+22,300
+3% +$11.3K ﹤0.01% 1966
2025
Q1 		$424K Sell
681,000
-142,900
-17% -$172K ﹤0.01% 1849
2024
Q4 		$1.38M Buy
823,900
+323,400
+65% +$497K ﹤0.01% 1307
2024
Q3 		$911K Buy
500,500
+432,900
+640% +$1.61M ﹤0.01% 1455
2024
Q2 		$408K Buy
67,600
+57,600
+576% +$708K ﹤0.01% 1966
2024
Q1 		$112K Buy
+10,000
New +$140K ﹤0.01% 2297
2023
Q4 		– Sell
-11,600
Closed -$55.7K – 2488
2023
Q3 		$55.7K Sell
11,600
-34,600
-75% -$188K ﹤0.01% 2269
2023
Q2 		$347K Sell
46,200
-73,800
-62% -$483K ﹤0.01% 1937
2023
Q1 		$542K Buy
120,000
+34,200
+40% +$259K ﹤0.01% 1908
2022
Q4 		$967K Sell
85,800
-24,000
-22% -$270K ﹤0.01% 1585
2022
Q3 		$1.05M Sell
109,800
-50,900
-32% -$593K ﹤0.01% 1497
2022
Q2 		$1.3M Buy
160,700
+47,900
+42% +$522K ﹤0.01% 1453
2022
Q1 		$1.91M Sell
112,800
-44,300
-28% -$756K 0.01% 1285
2021
Q4 		$3.38M Buy
+157,100
New +$6.78M 0.01% 942

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Two Sigma Advisers's ALXO Position: Q1 2026 in Review

Two Sigma Advisers sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 710,400 shares — an estimated $803K sold.

Two Sigma Advisers first reported a position in ALXO in Q4 2021 and held it in 16 quarters. The position peaked at $3.38M in Q4 2021. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Two Sigma Advisers reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 710,400 ALX Oncology shares in Q1 2026, an estimated $803K.
  • Two Sigma Advisers first reported a position in ALX Oncology in Q4 2021 and held it in 16 quarters.
  • Two Sigma Advisers's ALX Oncology position peaked at $3.38M in Q4 2021.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.